NASDAQ : ODTX
Odyssey Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 19.54 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 936.33M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Odyssey Therapeutics, Inc. (ODTX) reported revenue of 99.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | 99.00K | 2.98M | 4.47M | 1.04M | |
| Cost of Revenue | 120.72M | 121.18M | 112.58M | 112.28M | 101.52M |
| Gross Profit | -120.62M | -118.20M | -108.11M | -111.24M | -101.52M |
| Selling, General & Admin | 34.21M | 37.52M | 27.12M | 22.20M | 21.02M |
| Operating Expenses | 34.21M | 37.52M | 27.12M | 22.20M | 21.02M |
| Operating Income | -154.83M | -155.72M | -135.22M | -133.44M | -122.54M |
| Interest Expense | -43.00K | -17.00K | -18.00K | -335.00K | -291.00K |
| Interest & Investment Income | 8.86M | 6.35M | 8.49M | 8.79M | 3.92M |
| Currency Exchange Gain (Loss) | -158.00K | -47.00K | |||
| Other Non Operating Income (Expenses) | 1.39M | 1.20M | -302.00K | ||
| EBT Excluding Unusual Items | -144.62M | -148.18M | -127.05M | -125.14M | -118.95M |
| Gain (Loss) on Sale of Assets | -54.00K | ||||
| Asset Writedown | -5.44M | -5.44M | |||
| Other Unusual Items | -11.01M | 4.05M | -1.80M | -297.00K | -5.13M |
| Pretax Income | -161.07M | -149.57M | -128.85M | -125.49M | -124.32M |
| Income Tax Expense | -1.04M | -927.00K | 469.00K | 447.00K | 347.00K |
| Net Income | -160.03M | -148.65M | -129.32M | -125.94M | -124.67M |
| Preferred Dividends & Other Adjustments | 1.08M | 4.98M | |||
| Net Income to Common | -160.03M | -148.65M | -130.40M | -130.92M | -124.67M |
| Shares Outstanding (Basic) | 11.39M | 2.97M | 806.99K | 648.00K | 447.80K |
| Shares Outstanding (Diluted) | 11.39M | 2.97M | 806.99K | 648.00K | 447.80K |
| EPS (Basic) | -14.05 | -50.13 | -161.59 | -202.04 | -278.39 |
| EPS (Diluted) | -14.05 | -50.13 | -161.59 | -202.04 | -278.39 |
| Free Cash Flow | -132.74M | -130.70M | -118.23M | -117.78M | -112.87M |
| Free Cash Flow Per Share | -11.65 | -44.08 | -146.51 | -181.76 | -252.05 |
| Operating Margin | -156,392.93% | -5,232.39% | -3,023.77% | -12,867.79% | |
| Profit Margin | -161,643.43% | -4,994.86% | -2,915.94% | -12,624.88% | |
| Free Cash Flow Margin | -134,079.80% | -4,391.80% | -2,643.89% | -11,358.15% | |
| EBITDA | -150.27M | -150.81M | -130.03M | -128.53M | -119.77M |
| D&A For EBITDA | 4.56M | 4.91M | 5.19M | 4.91M | 2.76M |
| EBIT | -154.83M | -155.72M | -135.22M | -133.44M | -122.54M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Cash & Equivalents | 82.03M | 41.69M | 59.14M | 52.55M | 241.04M |
| Short-Term Investments | 228.54M | 139.67M | 70.22M | 134.45M | |
| Cash & Short-Term Investments | 310.57M | 181.36M | 129.35M | 187.00M | 241.04M |
| Prepaid Expenses | 10.89M | 9.30M | 6.16M | 5.54M | 7.67M |
| Total Current Assets | 321.46M | 190.66M | 135.51M | 192.54M | 248.71M |
| Property, Plant & Equipment | 21.92M | 26.01M | 39.47M | 46.73M | 52.77M |
| Long-Term Investments | 122.49M | 35.20M | 29.10M | ||
| Goodwill | 14.10M | 14.33M | 13.35M | 13.55M | 12.88M |
| Other Intangible Assets | 86.00K | 262.00K | 570.00K | 910.00K | 1.18M |
| Long-Term Deferred Charges | 100.00K | 5.00M | |||
| Other Long-Term Assets | 3.79M | 3.23M | 3.54M | 3.69M | 1.61M |
| Total Assets | 483.85M | 269.79M | 197.44M | 286.52M | 317.15M |
| Accounts Payable | 7.67M | 7.87M | 6.32M | 7.73M | 8.05M |
| Accrued Expenses | 11.50M | 12.95M | 10.00M | 9.92M | 9.85M |
| Current Portion of Leases | 5.46M | 5.21M | 4.58M | 3.86M | 1.72M |
| Current Income Taxes Payable | 177.00K | 548.00K | |||
| Current Unearned Revenue | 2.88M | 406.00K | 1.00M | ||
| Other Current Liabilities | 3.66M | 438.00K | 4.64M | 1.63M | |
| Total Current Liabilities | 28.30M | 26.48M | 28.41M | 22.09M | 22.80M |
| Long-Term Debt | 4.76M | ||||
| Long-Term Leases | 19.36M | 21.90M | 26.43M | 30.52M | 34.38M |
| Other Long-Term Liabilities | 14.97M | 6.13M | 10.18M | 8.38M | 8.08M |
| Total Liabilities | 62.63M | 54.51M | 65.02M | 60.99M | 70.02M |
| Common Stock | 5.00K | 2.00K | 1.00K | 1.00K | 1.00K |
| Additional Paid-In Capital | 1.08B | 79.61M | 38.30M | 27.24M | 15.73M |
| Retained Earnings | -659.19M | -568.14M | -419.49M | -289.09M | -158.17M |
| Comprehensive Income & Other | -505.00K | 245.00K | -1.34M | -858.00K | -2.18M |
| Total Common Equity | 421.22M | -488.28M | -382.53M | -262.71M | -144.62M |
| Shareholders' Equity | 421.22M | 215.28M | 132.41M | 225.53M | 247.13M |
| Total Liabilities & Equity | 483.85M | 269.79M | 197.44M | 286.52M | 317.15M |
| Total Debt | 24.82M | 27.11M | 31.01M | 34.38M | 40.86M |
| Net Cash (Debt) | 408.24M | 189.44M | 98.35M | 181.72M | 200.18M |
| Net Cash Per Share | 35.85 | 63.89 | 121.87 | 280.43 | 447.04 |
| Filing Date Shares Outstanding | 47.92M | 2.23M | 886.28K | 733.20K | 447.80K |
| Total Common Shares Outstanding | 47.89M | 2.23M | 886.28K | 733.20K | 447.80K |
| Working Capital | 293.17M | 164.18M | 107.09M | 170.45M | 225.91M |
| Book Value Per Share | 8.80 | -218.63 | -431.61 | -358.30 | -322.96 |
| Tangible Book Value | 407.04M | -502.87M | -396.44M | -277.17M | -158.68M |
| Tangible Book Value Per Share | 8.50 | -225.16 | -447.31 | -378.03 | -354.35 |
| Machinery | 16.84M | 20.37M | 22.46M | 22.21M | 19.11M |
| Leasehold Improvements | 401.00K | 501.00K | 306.00K | 272.00K | 206.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Net Income | -160.03M | -148.65M | -129.32M | -125.94M | -124.67M |
| Depreciation & Amortization | 4.56M | 4.91M | 5.19M | 4.91M | 2.76M |
| Loss (Gain) From Sale of Assets | 1.59M | 1.36M | 4.00K | 54.00K | |
| Asset Writedown & Restructuring Costs | 5.44M | 239.00K | |||
| Loss (Gain) From Sale of Investments | -1.01M | -1.52M | -4.46M | -3.26M | |
| Stock-Based Compensation | 15.89M | 14.32M | 8.69M | 6.26M | 5.52M |
| Other Operating Activities | 14.76M | -606.00K | 5.73M | 4.35M | 16.85M |
| Change in Accounts Payable | 757.00K | 2.06M | -1.70M | 2.24M | 3.27M |
| Change in Other Net Operating Assets | -8.64M | -6.79M | -1.61M | -1.35M | -3.81M |
| Operating Cash Flow | -132.13M | -129.47M | -117.47M | -112.73M | -99.84M |
| Capital Expenditures | -610.00K | -1.23M | -764.00K | -5.06M | -13.03M |
| Sale of Property, Plant & Equipment | 500.00K | 357.00K | 24.00K | ||
| Investment in Securities | -337.91M | -103.07M | 97.55M | -159.99M | |
| Investing Cash Flow | -338.02M | -103.94M | 96.78M | -165.02M | -13.03M |
| Long-Term Debt Issued | 4.88M | ||||
| Long-Term Debt Repaid | -4.76M | ||||
| Net Debt Issued (Repaid) | -4.76M | 4.88M | |||
| Issuance of Common Stock | 295.66M | 3.19M | 510.00K | 264.00K | 76.00K |
| Other Financing Activities | -1.04M | ||||
| Financing Cash Flow | 389.37M | 215.65M | 26.98M | 92.08M | 182.72M |
| Foreign Exchange Rate Adjustments | 52.00K | 316.00K | 50.00K | 5.00K | -23.00K |
| Net Cash Flow | -80.73M | -17.45M | 6.34M | -185.67M | 69.83M |
| Free Cash Flow | -132.74M | -130.70M | -118.23M | -117.78M | -112.87M |
| Free Cash Flow Margin | -134,079.80% | -4,391.80% | -2,643.89% | -11,358.15% | |
| Free Cash Flow Per Share | -11.65 | -44.08 | -146.51 | -181.76 | -252.05 |
| Levered Free Cash Flow | -85.05M | -66.42M | -78.21M | ||
| Unlevered Free Cash Flow | -85.04M | -66.41M | -78.00M | ||
| Cash Interest Paid | 22.00K | 10.00K | 18.00K | 156.00K | 291.00K |
| Cash Income Tax Paid | 221.00K | 260.00K | 495.00K | 319.00K | |
| Change in Working Capital | -7.88M | -4.73M | -3.31M | 896.00K | -544.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Market Capitalization | 936.33M | ||||
| Enterprise Value | 528.08M | ||||
| Debt / Equity Ratio | 0.06 | 0.13 | 0.23 | 0.15 | 0.17 |
| Net Debt / Equity Ratio | -0.97 | -0.88 | -0.74 | -0.81 | -0.81 |
| Net Debt / EBITDA Ratio | 2.72 | 1.26 | 0.76 | 1.41 | 1.67 |
| Net Debt / FCF Ratio | 3.08 | 1.45 | 0.83 | 1.54 | 1.77 |
| Asset Turnover | 0.01 | 0.02 | 0.00 | ||
| Quick Ratio | 10.98 | 6.85 | 4.55 | 8.47 | 10.57 |
| Current Ratio | 11.36 | 7.20 | 4.77 | 8.72 | 10.91 |
| Return on Equity (ROE) | -85.50% | -72.26% | -53.29% | ||
| Return on Assets (ROA) | -41.66% | -34.93% | -27.63% | ||
| Return on Capital Employed (ROCE) | -34.00% | -64.00% | -80.00% | -50.50% | -41.60% |
| Buyback Yield / Dilution | -1,383.37% | -267.45% | -24.54% | -44.71% |